Drug Delivery Devices Market Report 2026
Drug Delivery Devices Market Report 2026
Global Outlook – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035
Drug Delivery Devices Market Overview
• Drug Delivery Devices market size has reached to $95.99 billion in 2025 • Expected to grow to $128.94 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: The Impact Of Rising Healthcare Spending On The Drug Delivery Devices Market • Market Trend: Evonik Expands Targeted Oral Drug Delivery Capabilities With New EUDRACAP Colon Launch • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
What Is Covered Under Drug Delivery Devices Market?
Drug delivery devices are used to deliver specific drugs to a specific part of the body to cure diseases. Drug delivery devices used in various patient care settings, such as hospitals, diagnostic centers, clinics, and home care settings, are included in this market. The main routes of administration of drug delivery devices are oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery is a route of drug delivery in which a tablet or capsule is administered into the alimentary canal of a human being. The patient care settings are hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The various applications involved are cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and others.
What Is The Drug Delivery Devices Market Size and Share 2026?
The drug delivery devices market size has grown strongly in recent years. It will grow from $95.99 billion in 2025 to $102.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of injectable therapies, growth in hospital-based drug administration, increasing use of infusion devices, advancements in pharmaceutical formulations.What Is The Drug Delivery Devices Market Growth Forecast?
The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $128.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing adoption of home-based drug delivery, rising investments in personalized medicine, expansion of biologics and biosimilars, growing demand for connected delivery devices, increasing integration of digital health platforms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising use of self-administration injection systems, growing demand for controlled release technologies, expansion of wearable drug delivery platforms, enhanced focus on patient-centric designs.Global Drug Delivery Devices Market Segmentation
1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery 2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings 3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications Subsegments: 1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets 2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps 3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders 4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems 5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers 6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops 7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films 8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based ImplantsWhat Is The Driver Of The Drug Delivery Devices Market?
Increasing healthcare spending is expected to propel the growth of the drug delivery devices market going forward. Healthcare spending refers to the total financial resources allocated to health services and goods, including expenditures on hospitals, physicians, nursing care, prescription drugs, and public health programs. Healthcare spending is increasing due to factors like an aging population, rising prevalence of chronic diseases, advancements in medical technology, and higher costs of healthcare services and prescription drugs. Increased healthcare spending supports drug delivery device development by providing more funding for research, innovation, and the adoption of advanced technologies that improve treatment efficacy and patient outcomes. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, UK healthcare expenditure reached approximately $379 billion (£292 billion) in 2023. This marked a 5.6% nominal increase compared to 2022, a significant rise from the 0.9% growth observed in 2023. Therefore, the increasing healthcare spending is driving the growth of the drug delivery devices industry.Key Players In The Global Drug Delivery Devices Market
Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, GileroGlobal Drug Delivery Devices Market Trends and Insights
Major companies operating in the drug delivery devices market are focusing on developing advanced solutions such as targeted oral release capsules to enhance treatment efficacy and reduce systemic side effects. Targeted oral release capsules are engineered to withstand the acidic environment of the stomach and release active ingredients precisely in specific segments of the gastrointestinal tract, improving bioavailability and localizing therapy. For instance, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, launched its new EUDRACAP colon capsules designed for delivery of sensitive active substances to the ileo-colonic region. These capsules support the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides while preserving their integrity through tailored EUDRAGIT coatings. The EUDRACAP colon capsules also streamline formulation development with a ready-to-fill design and improve speed to market by reducing complexity in development. This innovation expands Evonik’s EUDRACAP platform and strengthens its system solutions portfolio for advanced oral drug delivery.What Are Latest Mergers And Acquisitions In The Drug Delivery Devices Market?
In October 2024, Aptar Pharma, a US-based provider of drug delivery systems and active material science solutions, acquired the device technology assets of SipNose Nasal Delivery Systems for an undisclosed amount. With this acquisition, Aptar aims to expand its intranasal drug delivery portfolio—strengthening its nose-to-brain delivery expertise and accelerating innovation in CNS therapeutic platforms. SipNose, an Israeli-based company, develops intranasal delivery devices for both liquid and dry powder formulations, enabling local, systemic, and direct brain delivery of active ingredients.Regional Outlook
North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Drug Delivery Devices Market?
The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Drug Delivery Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $102.15 billion |
| Revenue Forecast In 2035 | $128.94 billion |
| Growth Rate | CAGR of 6.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Route Of Administration, Patient Care Setting, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Drug Delivery Devices Market Report 2026 market was valued at $95.99 billion in 2025, increased to $102.15 billion in 2026, and is projected to reach $128.94 billion by 2030.
request a sample hereThe expected CAGR for the Drug Delivery Devices Market Report 2026 market during the forecast period 2025–2030 is 6.0%.
request a sample hereMajor growth driver of the market includes: The Impact Of Rising Healthcare Spending On The Drug Delivery Devices Market in the Drug Delivery Devices Market Report 2026 market. For further insights on this market,
request a sample hereThe drug delivery devices market covered in this report is segmented –
1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants
request a sample here1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants
Major trend in this market includes: Evonik Expands Targeted Oral Drug Delivery Capabilities With New EUDRACAP Colon Launch For further insights on this market,
request a sample hereMajor companies operating in the Drug Delivery Devices Market Report 2026 market are Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero
request a sample hereNorth America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here